共 50 条
- [41] Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
- [42] Congenital Adrenal Hyperplasia caused by compound heterozygosity of two novel CYP11B1gene variants [J]. HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 197 - 198
- [45] Two intronic variants of CYP11B1 and CYP17A1 disrupt mRNA splicing and cause congenital adrenal hyperplasia (CAH) [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (09): : 1225 - 1229
- [48] Compound heterozygosity of a novel Q73X mutation and a known R141X mutation in CYP11B1 resulting in 11β-hydroxylase deficiency in a Chinese boy with congenital adrenal hyperplasia [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2021, 211
- [49] Correction: Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations [J]. European Journal of Human Genetics, 2020, 28 : 692 - 692
- [50] Late-onset adrenal hypoplasia congenita caused by a novel mutation of the DAX-1 gene [J]. European Journal of Pediatrics, 2009, 168 : 329 - 331